Mirvetuximab soravtansine Antibody
Selected Variant
GTR18398568-01
Size: 1 mg
Mirvetuximab soravtansine (IMGN853) is an antibody-drug conjugate (ADC) targeting folate receptor alpha (FRα) for cancer research. It delivers a cytotoxic payload to inhibit proliferation and has demonstrated activity in preclinical models of ovarian cancer, including studies involving drug-resistant cell lines and xenograft models.
Product Specifications
Product Name Alternative
Mirvetuximab soravtansine, IMGN 853, IMGN853, IMGN-853, FRα, TAK-853
Target
Antifolate
Conjugation
Unconjugated
Field of Research
Cell Biology
Concentration
9.72 mg/mL
Purity
90.53% (May vary between batches)
Molecular Weight
145.76 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC881775-500 1x 500 µL
CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) (CFTR/1775R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682502-500 1x 500 µL
RCAS1 / Estrogen Receptor Binding Site Associated, Antigen 9 (CPTC-EBAG9-2), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
A00863 100 µg/Vial
Anti-Osteoprotegerin/TNFRSF11B Antibody Picoband®
Sign In for Pricing
View Details 
A10280-1-APC 100 µg/Vial
Anti-SMC1B Antibody Picoband®, APC Conjugate
Sign In for Pricing
View Details 
BNC882236-500 1x 500 µL
Cystatin A (CPTC-CSTA-1), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details